Correlation Between Apogee Therapeutics, and GENERAL
Specify exactly 2 symbols:
By analyzing existing cross correlation between Apogee Therapeutics, Common and GENERAL MTRS FINL, you can compare the effects of market volatilities on Apogee Therapeutics, and GENERAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of GENERAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and GENERAL.
Diversification Opportunities for Apogee Therapeutics, and GENERAL
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Apogee and GENERAL is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and GENERAL MTRS FINL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GENERAL MTRS FINL and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with GENERAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GENERAL MTRS FINL has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and GENERAL go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and GENERAL
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 28.08 times more return on investment than GENERAL. However, Apogee Therapeutics, is 28.08 times more volatile than GENERAL MTRS FINL. It trades about 0.02 of its potential returns per unit of risk. GENERAL MTRS FINL is currently generating about -0.05 per unit of risk. If you would invest 4,092 in Apogee Therapeutics, Common on November 3, 2024 and sell it today you would earn a total of 44.00 from holding Apogee Therapeutics, Common or generate 1.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apogee Therapeutics, Common vs. GENERAL MTRS FINL
Performance |
| Timeline |
| Apogee Therapeutics, |
| GENERAL MTRS FINL |
Apogee Therapeutics, and GENERAL Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apogee Therapeutics, and GENERAL
The main advantage of trading using opposite Apogee Therapeutics, and GENERAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, GENERAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GENERAL will offset losses from the drop in GENERAL's long position.| Apogee Therapeutics, vs. Lithia Motors | Apogee Therapeutics, vs. Contextlogic | Apogee Therapeutics, vs. Albertsons Companies | Apogee Therapeutics, vs. Titan Machinery |
| GENERAL vs. Afya | GENERAL vs. Udemy Inc | GENERAL vs. RLJ Lodging Trust | GENERAL vs. Target Hospitality Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |